🇺🇸 FDA
Patent

US 8492403

Bicyclic derivatives as modulators of voltage gated ion channels

granted A61PA61P1/00A61P13/02

Quick answer

US patent 8492403 (Bicyclic derivatives as modulators of voltage gated ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P1/00, A61P13/02, A61P19/02, A61P21/00